Furthermore, in the B16.OVA melanoma model, systemic administration of IL-33 combined with injection of dectin-1-activated bone marrow-derived DC induced activation and PD-1 expression in OVA-specific CD4+ T cells (45). The gene discussed is PDCD1; the disease is melanoma.